Bioxel Pharma Signs a Supply Agreement with a Medical Device Manufacturer

SAINTE-FOY, QUEBEC -- (MARKET WIRE) -- March 14, 2007 -- Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, today announced the completion of a paclitaxel supply agreement with a medical device company specialized in coated stents. The three-year renewable agreement provides for exclusive paclitaxel supplies to fulfill the client's needs from development through commercialization.

Back to news